Yifan Xinfu Pharmaceutical Co Ltd (002019) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.005x

Based on the latest financial reports, Yifan Xinfu Pharmaceutical Co Ltd (002019) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥40.18 Million ≈ $5.88 Million USD) by net assets (CN¥8.71 Billion ≈ $1.27 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Yifan Xinfu Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2024)

This chart illustrates how Yifan Xinfu Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Yifan Xinfu Pharmaceutical Co Ltd (002019) financial obligations for a breakdown of total debt and financial obligations.

Yifan Xinfu Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yifan Xinfu Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Worthington Steel Inc
NYSE:WS
0.074x
Aarti Industries Limited
NSE:AARTIIND
0.098x
Gränges AB (publ)
ST:GRNG
0.013x
Stora Enso Oyj A
HE:STEAV
0.007x
RLX TECH. SP.ADR/1 CL.A
F:3CM
N/A
LeMaitre Vascular Inc
NASDAQ:LMAT
0.076x
BaoViet Holdings
VN:BVH
-0.311x
Werner Enterprises Inc
NASDAQ:WERN
0.032x

Annual Cash Flow Conversion Efficiency for Yifan Xinfu Pharmaceutical Co Ltd (2003–2024)

The table below shows the annual cash flow conversion efficiency of Yifan Xinfu Pharmaceutical Co Ltd from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see 002019 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥8.43 Billion
≈ $1.23 Billion
CN¥640.73 Million
≈ $93.76 Million
0.076x +80.06%
2023-12-31 CN¥8.25 Billion
≈ $1.21 Billion
CN¥348.58 Million
≈ $51.01 Million
0.042x -18.18%
2022-12-31 CN¥9.15 Billion
≈ $1.34 Billion
CN¥472.07 Million
≈ $69.08 Million
0.052x +50.34%
2021-12-31 CN¥8.78 Billion
≈ $1.28 Billion
CN¥301.23 Million
≈ $44.08 Million
0.034x -73.01%
2020-12-31 CN¥8.72 Billion
≈ $1.28 Billion
CN¥1.11 Billion
≈ $162.21 Million
0.127x +6.13%
2019-12-31 CN¥7.82 Billion
≈ $1.14 Billion
CN¥937.24 Million
≈ $137.15 Million
0.120x -29.51%
2018-12-31 CN¥6.89 Billion
≈ $1.01 Billion
CN¥1.17 Billion
≈ $171.34 Million
0.170x +1.79%
2017-12-31 CN¥6.78 Billion
≈ $992.46 Million
CN¥1.13 Billion
≈ $165.75 Million
0.167x -23.88%
2016-12-31 CN¥3.90 Billion
≈ $570.77 Million
CN¥855.85 Million
≈ $125.24 Million
0.219x +57.24%
2015-12-31 CN¥2.88 Billion
≈ $421.52 Million
CN¥401.96 Million
≈ $58.82 Million
0.140x +154.00%
2014-12-31 CN¥2.54 Billion
≈ $372.19 Million
CN¥139.74 Million
≈ $20.45 Million
0.055x -38.38%
2013-12-31 CN¥384.95 Million
≈ $56.33 Million
CN¥34.32 Million
≈ $5.02 Million
0.089x +43.45%
2012-12-31 CN¥480.81 Million
≈ $70.36 Million
CN¥29.88 Million
≈ $4.37 Million
0.062x +155.24%
2011-12-31 CN¥469.52 Million
≈ $68.71 Million
CN¥-52.82 Million
≈ $-7.73 Million
-0.113x -134.03%
2010-12-31 CN¥703.64 Million
≈ $102.96 Million
CN¥-33.82 Million
≈ $-4.95 Million
-0.048x -174.89%
2009-12-31 CN¥913.15 Million
≈ $133.62 Million
CN¥58.61 Million
≈ $8.58 Million
0.064x -56.02%
2008-12-31 CN¥570.87 Million
≈ $83.54 Million
CN¥83.31 Million
≈ $12.19 Million
0.146x -67.81%
2007-12-31 CN¥548.55 Million
≈ $80.27 Million
CN¥248.71 Million
≈ $36.39 Million
0.453x +351.02%
2006-12-31 CN¥324.46 Million
≈ $47.48 Million
CN¥32.62 Million
≈ $4.77 Million
0.101x +33.73%
2005-12-31 CN¥320.93 Million
≈ $46.96 Million
CN¥24.12 Million
≈ $3.53 Million
0.075x -30.63%
2004-12-31 CN¥309.98 Million
≈ $45.36 Million
CN¥33.59 Million
≈ $4.91 Million
0.108x -19.25%
2003-12-31 CN¥94.31 Million
≈ $13.80 Million
CN¥12.65 Million
≈ $1.85 Million
0.134x --

About Yifan Xinfu Pharmaceutical Co Ltd

SHE:002019 China Drug Manufacturers - General
Market Cap
$1.99 Billion
CN¥13.60 Billion CNY
Market Cap Rank
#6284 Global
#1390 in China
Share Price
CN¥11.18
Change (1 day)
-0.53%
52-Week Range
CN¥11.18 - CN¥16.29
All Time High
CN¥32.51
About

Yifan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products, raw materials, and polymer materials in Southeast Asia, Europe and North America, Singapore, South Korea, Italy, China, Germany, and the United States. It offers Chinese patent medicines, chemical medicines and biological medicines; and vitamin products, including vitamin B5 an… Read more